Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops

References

• FreemanPDKahookMYPreservatives in topical ophthalmic medications: historical and clinical perspectivesExpert Rev Ophthalmol2009415964
   Google Scholar
• BaudouinCLabbéALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res201029431233420302969
   PubMed Web of Science ®Google Scholar
• GassetARBenzalkonium chloride toxicity to the human corneaAm J Ophthalmol1977842169171888887
   PubMed Web of Science ®Google Scholar
• GassetARIshiiYKaufmanHEMillerTCytotoxicity of ophthalmic preservativesAm J Ophthalmol1974781981054835060
   PubMed Web of Science ®Google Scholar
• AmmarDANoeckerRJKahookMYEffects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cellsAdv Ther2010271183784520931366
   PubMed Web of Science ®Google Scholar
• Herrero VanrellRPreservatives in ophthalmic formulations: an overviewArch Soc Esp Oftalmol200782531532 Spanish17846940
   PubMedGoogle Scholar
• NoeckerROphthalmic preservatives: considerations for long-term use in patients with dry eye or glaucomaRev Ophthalmol2001867379
   Google Scholar
• AsbellPAPotapovaNEffects of topical antiglaucoma medications on the ocular surfaceOcul Surf200531274017131003
   PubMed Web of Science ®Google Scholar
• PisellaPJFillacierKElenaPPDebbaschCBaudouinCComparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbitsOphthalmic Res20003213810657748
   PubMed Web of Science ®Google Scholar
• HerrerasJMPastorJCCalongeMAsensioVMOcular surface alteration after long-term treatment with an antiglaucomatous drugOphthalmology1992997108210881495787
   PubMed Web of Science ®Google Scholar
• KuppensEVvan BestJASterkCCde KeizerRDecreased basal tear turnover in patients with untreated primary open-angle glaucomaAm J Ophthalmol1995120141467611328
   PubMed Web of Science ®Google Scholar
• Baffa LdoPRicardoJRDiasACTear film and ocular surface alterations in chronic users of antiglaucoma medicationsArq Bras Oftalmol2008711182118408831
   PubMed Web of Science ®Google Scholar
• BursteinNLPreservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneasInvest Ophthalmol Vis Sci19801933083137358482
   PubMed Web of Science ®Google Scholar
• ChaSHLeeJSOumBSKimCDCorneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitroClin Experiment Ophthalmol200432218018415068436
   PubMed Web of Science ®Google Scholar
• AyakiMIwasawaAInoueYToxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cellsClin Ophthalmol201041217122221060675
   PubMedGoogle Scholar
• AyakiMYaguchiSIwasawaAKoideRCytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cellsClin Experiment Ophthalmol200836655355918954319
   PubMed Web of Science ®Google Scholar
• CollinHBCarrollNUltrastructural changes to the corneal endothelium due to benzalkonium chlorideActa Ophthalmol (Copenh)19866422262313727965
   PubMed Web of Science ®Google Scholar
• CollinHBUltrastructural changes to corneal stromal cells due to ophthalmic preservativesActa Ophthalmol (Copenh)198664172783083641
   PubMed Web of Science ®Google Scholar
• EpsteinSPChenDAsbellPAEvaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cellsJ Ocul Pharmacol Ther200925541542419857103
   PubMed Web of Science ®Google Scholar
• BaudouinCLiangHHamardPThe ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathwaysOphthalmology2008115110911517532048
   PubMed Web of Science ®Google Scholar
• NoeckerREffects of common ophthalmic preservatives on ocular healthAdv Ther200118520521511783457
   PubMed Web of Science ®Google Scholar
• StevensAMKestelynPADe BacquerDKestelynPGBenzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trialActa Ophthalmol2012903e221e22422489894
   PubMed Web of Science ®Google Scholar
• AmmarDAKahookMYEffects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cellsMol Vis2011171806181321750606
   PubMed Web of Science ®Google Scholar
• AmmarDAKahookMYEffects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell linesBr J Ophthalmol201195101466146921602479
   PubMed Web of Science ®Google Scholar
• GotoYIbarakiNMiyakeKHuman lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timololArch Ophthalmol200312183583912796255
   PubMed Web of Science ®Google Scholar
• BroadwayDCChangLPTrabeculectomy, risk factors for failure and the preoperative state of the conjunctivaJ Glaucoma200110323724911442190
   PubMed Web of Science ®Google Scholar
• MiyakeKIbarakiNGotoYESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathyJ Cataract Refract Surg20032991800181014522305
   PubMed Web of Science ®Google Scholar
• JaenenNBaudouinCPouliquenPManniGFigueiredoAZeyenTOcular symptoms and signs with preserved and preservative-free glaucoma medicationsEur J Ophthalmol200717334134917534814
   PubMed Web of Science ®Google Scholar
• KuppensEVde JongCAStolwijkTRde KeizerRJvan BestJAEffect of timolol with and without preservative on the basal tear turnover in glaucomaBr J Ophthalmol19957943393427742279
   PubMed Web of Science ®Google Scholar
• ManniGCentofantiMOddoneFParravanoMBucciMInterleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockersAm J Ophthalmol20051391727715652830
   PubMed Web of Science ®Google Scholar
• IshibashiTYokoiNKinoshitaSComparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chlorideJ Glaucoma200312648649014646684
   PubMed Web of Science ®Google Scholar
• de JongCSolwijkTKuppensEde KazierRvan BestJTopical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucomaGraefes Arch Clin Exp Ophthalmol199423242212248034210
   PubMed Web of Science ®Google Scholar
• FurrerPBergerJMayerJMGurnyRA comparative study of the ocular tolerance of 3 timolol-based preparations: the influence of preservatives on ocular toleranceJ Fr Ophthalmol20012411319 French
   Web of Science ®Google Scholar
• ChabiAVarmaRTsaiJCRandomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma and ocular hypertensionAm J Ophthalmol201215361187119622310086
   PubMed Web of Science ®Google Scholar
• BronAVelasqueLRebicaHPouliquenPElenaPPRoulandJFComparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprostJ Fr Ophthalmol2004279 Pt 1971977 French
   Web of Science ®Google Scholar
• BronAChiambarettaFPouliquenRRigalDRoulandJFEfficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertensionJ Fr Ophthalmol2003267668674 French
   Web of Science ®Google Scholar
• FurrerPMayerJMGurnyROcular tolerance of preservatives and alternativesEur J Pharm Biopharm200253326328011976014
   PubMed Web of Science ®Google Scholar